SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019387
Filing Date
2020-04-29
Accepted
2020-04-29 06:03:55
Documents
7
Period of Report
2020-06-10
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A reta-def14a_20200610.htm DEF 14A 2278573
2 GRAPHIC giw4tyrwmyal000002.jpg GRAPHIC 1206
3 GRAPHIC giw4tyrwmyal000005.jpg GRAPHIC 79792
4 GRAPHIC giw4tyrwmyal000004.jpg GRAPHIC 27119
5 GRAPHIC giw4tyrwmyal000001.jpg GRAPHIC 6386
6 GRAPHIC giw4tyrwmyal000003.jpg GRAPHIC 6515
7 GRAPHIC giw4tyrwmyal000006.jpg GRAPHIC 46494
  Complete submission text file 0001564590-20-019387.txt   2511184
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37785 | Film No.: 20827141
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences